Virology
NanoViricides Advances Measles Drug Development with Promising Broad-Spectrum Antiviral
NanoViricides is developing NV-387, a broad-spectrum antiviral drug candidate targeting measles amid declining vaccination rates. The drug shows potential for addressing infectious disease challenges with its unique therapeutic approach.
April 29, 2025
GeoVax Highlights Mpox Threat After North Carolina Wastewater Detection
Wastewater samples in North Carolina reveal the first state detection of Clade I Mpox, a more virulent strain with higher transmissibility. GeoVax responds by emphasizing the need for expanded vaccine preparedness and domestic manufacturing capabilities.
April 24, 2025